Drug-induced phospholipidosis

被引:267
作者
Anderson, Nora
Borlak, Juergen
机构
[1] Fraunhofer Inst Toxicol & Expt Med, D-30625 Hannover, Germany
[2] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-30625 Hannover, Germany
关键词
drug-induced phospholipidosis; lysosome; cationic amphiphilic drug; lamellar body;
D O I
10.1016/j.febslet.2006.08.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug-induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. brgans affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug-altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug-induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug-induced phospholipidosis for an improved understanding of adverse drug reaction. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:5533 / 5540
页数:8
相关论文
共 72 条
[61]  
SCHMITZ G, 1991, J LIPID RES, V32, P1539
[62]  
Schneider P, 1997, MICROSC RES TECHNIQ, V36, P253
[63]   ANTI-SCHIZOPHRENIC DRUGS - MEMBRANE RECEPTOR-SITES OF ACTION [J].
SEEMAN, P .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (19) :1741-1748
[64]   PERHEXILENE - EFFECTS ON HEPATIC LYSOSOMAL FUNCTION IN RATS [J].
SEWELL, RB ;
HOROWITZ, JD ;
GRINPUKEL, SA ;
MARTIN, G .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (01) :25-32
[65]   Jamming the endosomal system: lipid rafts and lysosomal storage diseases [J].
Simons, K ;
Gruenberg, J .
TRENDS IN CELL BIOLOGY, 2000, 10 (11) :459-462
[66]   TIME-DEPENDENT EFFECTS OF CHLOROQUINE ON PH OF HEPATOCYTE LYSOSOMES [J].
TIETZ, PS ;
YAMAZAKI, K ;
LARUSSO, NF .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (06) :1419-1421
[67]   Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin [J].
Van Bambeke, F ;
Gerbaux, C ;
Michot, JM ;
d'Yvoire, MB ;
Montenez, JP ;
Tulkens, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :761-767
[68]   Interaction of the macrolide azithromycin with phospholipids .1. Inhibition of lysosomal phospholipase A(1) activity [J].
VanBambeke, F ;
Montenez, JP ;
Piret, J ;
Tulkens, PM ;
Courtoy, PJ ;
MingeotLeclercq, MP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (1-2) :203-214
[69]   Lysosomal storage disorders [J].
Vellodi, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (04) :413-431
[70]   DIVALENT-CATIONS AND CHLORPROMAZINE CAN INDUCE NON-BILAYER STRUCTURES IN PHOSPHATIDIC ACID-CONTAINING MODEL MEMBRANES [J].
VERKLEIJ, AJ ;
DEMAAGD, R ;
LEUNISSENBIJVELT, J ;
DEKRUIJFF, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 684 (02) :255-262